Johnson & Johnson slammed with $8bn for drug that makes men grow breast
In a suit filed by Nicholas Murray, a Philadelphian Jury has awarded a sum of $8 billion against US drug firm, Johnson & Johnson, for claims that the plaintiff was not warned that Risperdal, an anti-psychotic drug, could cause breast…